Stents Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)

The Stents market is segmented by Product (Coronary stents, Peripheral stents, and Stent Implants), by Material and geography.

Stents Market Snapshot

Stents Market Snapshot
Study Period: 2018 - 2026
Base Year: 2021
Fastest Growing Market: Asia Pacific
Largest Market: North America
CAGR: 5.3 %

Need a report that reflects how COVID-19 has impacted this market and its growth?

Market Overview

The major factors found propelling the growth of the stents market include the increasing prevalence of chronic illnesses like cardiovascular diseases, rising the geriatric population, and the technological advancements in stents.

The prevalence of chronic illnesses has been increasing in the recent decades. Coronary Vascular Diseases (CVD) were the number one cause of death globally as per World Health Organisation 2017. An estimated 17.9 million people died from CVDs in 2016, which represents 31% of all global deaths. Of these deaths, 85% are due to heart attack and stroke. Hence as stents are used in surgeries, the market is expected to grow with such high prevalence.

There has also been a high demand for minimally invasive surgical procedures that is likely to significantly drive the stent market. Thus, there has been a reduction in post-operative trauma and complications with the use of a minimally invasive surgical procedure, which is the major growth driver. Reduced hospital stays and lesser healing time are the other advantages associated with the use of advanced and miniaturized stents.

Scope of the Report

A stent is a metal or plastic tube inserted into the lumen of an anatomic vessel or duct to keep the passageway open.

In the report, a detailed analysis of the stents market is provided. The market is evaluated by collating revenues generated across segments, categorized by product, material and geography.

By Product
Coronary stents
Drug-eluting stents
Bare-metal coronary stents
Bioabsorbable stents
Peripheral stents
Iliac stents
Femoral-popliteal stents
Renal & related stents
Carotid stents
Stent Implants
By Material
Metallic biomaterials
Polymeric biomaterials
Natural biomaterials
North America
United States
United Kingdom
Rest of Europe
South Korea
Rest of Asia-Pacific
Middle-East and Africa
South Africa
Rest of Middle-East and Africa
South America
Rest of South America

Report scope can be customized per your requirements. Click here.

Key Market Trends

Coronary Stents are expected to cover a large share of stents global market

A coronary stent is a tube-shaped device placed in the coronary arteries that supply blood to the heart, to keep the arteries open in the treatment of coronary heart disease. In the recent times, usage of coronary stent in surgical procedures has increased due to increase in cardiovascular disease. According to American Heart Association, the global deaths due to cardiovascular disease was 17.6 million in 2016 and is expected to rise to 23.6 million in 2030.

With rise in number of deaths due to cardiovascular disease, the demand for surgery involving coronary stents is expected to increase, helping the stents market grow.

Stents Market Trends

North America is expected to dominate the market

According center for American Heart Association, cardiovascular disease (CVD), which was listed as the leading cause of death, accounted for more than 800,000 deaths in the US in 2016, which represents approximately 1 of every 3 deaths. Between 2013 and 2016, 121.5 million American adults had some form of cardiovascular disease. Coronary Heart Disease was the leading cause (43.2%) of deaths attributable to cardiovascular disease, followed by stroke (16.9%).

However, as United States has a developed healthcare system structure, it invests a lot in awareness and treatments. According to American Heart Association, between 2014 and 2015, direct and indirect costs of total cardiovascular diseases and stroke were USD 351.2 billion.

Owing to aforemention factors, the United States stents market is expected to increase in the forecast period.

Stents Market

Competitive Landscape

There has been a presence of a considerable number of companies that are significantly contributing to the market growth. Product innovation and ongoing R&D activities to develop advanced technologies has helped in boosting the growth of the market. The competition is fierce due to the consolidated nature of the market with top three players reporting to occupy major share in the market. The key players in the stents market are adopting various strategic moves to sustain the intense competition.

Table of Contents


    1. 1.1 Study Deliverables

    2. 1.2 Study Assumptions

    3. 1.3 Scope of the Study




    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Increasing Prevalence of Chronic Diseases

      2. 4.2.2 Increasing Geriatric Population

      3. 4.2.3 Technological Advancements in Stent Development

    3. 4.3 Market Restraints

      1. 4.3.1 Stringent Approval Process for Stents

      2. 4.3.2 High Product Recalls

    4. 4.4 Porter's Five Force Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry


    1. 5.1 By Product

      1. 5.1.1 Coronary stents

        1. Drug-eluting stents

        2. Bare-metal coronary stents

        3. Bioabsorbable stents

      2. 5.1.2 Peripheral stents

        1. Iliac stents

        2. Femoral-popliteal stents

        3. Renal & related stents

        4. Carotid stents

      3. 5.1.3 Stent Implants

    2. 5.2 By Material

      1. 5.2.1 Metallic biomaterials

      2. 5.2.2 Polymeric biomaterials

      3. 5.2.3 Natural biomaterials

    3. 5.3 Geography

      1. 5.3.1 North America

        1. United States

        2. Canada

        3. Mexico

      2. 5.3.2 Europe

        1. Germany

        2. United Kingdom

        3. France

        4. Italy

        5. Spain

        6. Rest of Europe

      3. 5.3.3 Asia-Pacific

        1. China

        2. Japan

        3. India

        4. Australia

        5. South Korea

        6. Rest of Asia-Pacific

      4. 5.3.4 Middle-East and Africa

        1. GCC

        2. South Africa

        3. Rest of Middle-East and Africa

      5. 5.3.5 South America

        1. Brazil

        2. Argentina

        3. Rest of South America


    1. 6.1 Company Profiles

      1. 6.1.1 Boston Scientific Corporation

      2. 6.1.2 Abbott Laboratories

      3. 6.1.3 Medtronic PLC

      4. 6.1.4 B. Braun Melsungen AG

      5. 6.1.5 Becton, Dickinson and Company

      6. 6.1.6 Microport Scientific Corporation

      7. 6.1.7 Stentys S.A.

      8. 6.1.8 Biotronik SE & Co. KG

      9. 6.1.9 Cook Group

      10. 6.1.10 Terumo Corporation

    2. *List Not Exhaustive

**Competitive Landscape covers- Business Overview, Financials, Products and Strategies and Recent Developments

You can also purchase parts of this report. Do you want to check out a section wise price list?

Frequently Asked Questions

The Stents Market market is studied from 2018 - 2026.

The Stents Market is growing at a CAGR of 5.3% over the next 5 years.

Asia Pacific is growing at the highest CAGR over 2021- 2026.

North America holds highest share in 2020.

B. Braun Melsungen AG, Boston Scientific Corporation, Medtronic PLC, Abbott Laboratories, Becton Dickinson and Company are the major companies operating in Stents Market.

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!